Valeant Pharmaceuticals International Inc on Wednesday named board member and former Chief Financial Officer Howard Schiller as interim chief executive officer to replace Michael Pearson, who has been in the hospital with severe pneumonia since late … Read the full article on Reuters »
Valeant names interim CEO; timing of Pearson"s return unknown - Reuters
No comments:
Post a Comment